These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 308122)

  • 21. Stage II and III-A non-small cell cancer of the lung: results of surgical resection at Fairfax Hospital.
    Kiernan PD; Sheridan M; Byrne WD; Fulcher T; Attai D; Seigel L; Hull M
    Va Med Q; 1994; 121(3):172-8. PubMed ID: 8061068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of adenosine deaminase activity with T-lymphocytes and subsets in pulmonary tuberculosis and bronchogenic carcinoma.
    Pushpakom R; Ong-Ajyooth S; Bovornkitti S
    J Med Assoc Thai; 1990 May; 73(5):244-8. PubMed ID: 2212911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte subsets in pulmonary venous and arterial blood of lung cancer patients.
    Sato Y; Mukai K; Watanabe S; Gotoh M; Matsuno Y; Furuya S; Shimosato Y
    Jpn J Clin Oncol; 1989 Sep; 19(3):229-36. PubMed ID: 2478739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchogenic cancer associated with head and neck tumors. Survival analysis of 194 patients.
    Massard G; Roeslin N; Jung GM; Dumont P; Wihlm JM; Morand G
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):218-27. PubMed ID: 8393506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis, stage, and prognosis of lung carcinoma by preoperative assay of lung tumor antigen-sensitive T lymphocytes.
    Ramey WG; Fitzpatrick HF; Hashim GA; Munther AS; Swistel AJ; Burrows WB
    J Thorac Cardiovasc Surg; 1980 Nov; 80(5):656-60. PubMed ID: 6968856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
    Fujisawa T; Yamaguchi Y
    Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
    Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of preoperative radiotherapy on resection rate and long-term efficacy for patients with stage II and III lung carcinomas].
    Zhang LB; Zhou NK; Sun YE; Liu Y
    Ai Zheng; 2002 May; 21(5):514-7. PubMed ID: 12452043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
    Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of patients in stage I and II primary lung cancer with curative resection].
    Nishimura H; Morimoto M; Haniuda M; Masai M; Kobayashi O; Yamanda T; Aoki T; Iida F
    Kyobu Geka; 1992 Jul; 45(7):582-5. PubMed ID: 1320146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of squamous cancer of the lung correlates with alterations in circulating T cells.
    Ginns LC; Rogol PR; Murphy M
    Diagn Immunol; 1983; 1(3):155-61. PubMed ID: 6333956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of pre-treatment lymphocyte count and T cell levels in localized bronchogenic carcinoma.
    Dellon AL; Potvin C; Chretien PB
    J Surg Oncol; 1979; 12(3):253-61. PubMed ID: 228122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of radiotherapy on lymphocyte cytotoxicity against allogeneic lung cancer cells in patients with bronchogenic carcinoma.
    Toyohira K; Yasumoto K; Manabe H; Ohta M; Terashima H; Takayama K; Shinohara S; Nomoto K
    Gan; 1979 Feb; 70(1):9-14. PubMed ID: 446978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed lymphocyte reactivity of patients with solid tumors.
    Harris J; Stewart TH
    Oncology; 1974; 30(1):33-42. PubMed ID: 4280032
    [No Abstract]   [Full Text] [Related]  

  • 39. Thymosin immunotherapy in patients with small cell carcinoma of the lung: correlation of in vitro studies with clinical course.
    Lipson SD; Chretien PB; Makuch R; Kenady DE; Cohen MH
    Cancer; 1979 Mar; 43(3):863-70. PubMed ID: 218717
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma.
    Weissler JC; Nicod LP; Toews GB
    Am Rev Respir Dis; 1987 Jun; 135(6):1353-7. PubMed ID: 3592408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.